Sangeeta Pendurkar, currently VP of Coca-Cola, will replace Anupam Dutta as MD of Kellogg's India in two months. Large US banks and manufacturers are putting off overseas contracts due to economic concerns, which could hurt India's outsourcing industry. Toyota plans to launch 6 new hybrid models by 2012, targeting markets in Japan and the US, including luxury brand Lexus. AstraZeneca signed a licensing and supply deal with Intas Pharma to provide 30 genetic and oncology products.

1. Weekly news13th Sep-19th Sep, 2010 Prepared By:- AnkitSood MBA-2A

2. COKE V-P Pendurkar to sit at head of Kellogg’s India Table SangeetaPendurkar, VP-Coke(strategy and commercial beverages) taking over as MD of Kellogg’s India in two months. Ms Pendurkar to replace AnupamDutta(relocated to South Africa). In coke she steered the revamp of company’s Georgia tea and coffeeand extending coca cola’s juice brand Minute Maid to Nimbu Fresh

3. IT companys face tough times as US firms put off orders AMERICA’s worsening economic climate could end up hurting the fortunes of india’s $50 billion outsourcing industry as US start avoiding overseas contracts fearing a backlash. Large banks and manufacturing companies in the US are wary about the demand for their products and have been trimming their payroll in order to boost profit

4. Toyota to launch 6 new hybrid models by 2012 Toyota motor to launch 6 more hybrid models by 2012 Japan and US expected to be among the major market for such vehicles The 6 planned gas electric hybrids will include hybrid only new models in addition to hybrid version of the existing gasoline vehicles such as luxury lexus CT100h hybrid model to be launched next year.

5. AstraZeneca inks licensing supply deal with Intas London based bio pharma company AstraZenaca has entered into a licensing and supply agreement with Ahmedabad based IntasPharma for supplying genetic and high end encological products. The supply deal is for 30 products.

6. THANK YOU